In 2019, dietary supplement sales reached a record of $48.7 billion. Supplement sales continue to skyrocket, with consumers searching desperately for options to stay healthy and keeping supplement makers busy.
When Congress passed the Dietary Supplement Health and Education Act of 1994, it changed the game for dietary supplements in the United States. This groundbreaking legislation classified dietary supplements as a special category of food.
In the dietary supplement business, developing new products to get into the hands of consumers can be expensive and time-consuming. Finding the best ingredients, and the suppliers who can provide them quickly is a constant struggle. Political disputes over imported ingredients make it even more difficult for supplement makers to stay on schedule and under budget.
But regulators aren’t alone in demanding documented proof of compliance. Consumers increasingly want more information on what they’re buying, with a growing demand for clean labels and verified claims.
All of this uncertainty puts more pressure on supplement manufacturers and brand owners, who must gather, manage, and store more documentation than ever before. Supplement makers could spend more money on staff. Or they could invest in a smarter, more efficient solution.
In this webinar, Tim Lombardo from Eurofins explained the rise of supplements in America. Tim covered the dangers of certain supplements and the serious medical complications that can occur when misused or ingested in combination with prescription and over-the-counter medications.
How to recognize the top “at risk” supplements in the industry.
How to identify the FDA’s position on CBD-infused supplements and the top “at risk” supplements.
Why protecting consumer confidence is crucial for future success.
Why U.S. consumption of dietary supplements is on the rise and what’s driving it.